# Deferasirox

NDC: 69097-570
Generic name: Deferasirox
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: GRANULE
Routes: ORAL
Marketing started: 20220223

FDA application: ANDA215026

## Active ingredients

- DEFERASIROX: 360 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-570"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-570
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=31c5a91f-e901-418b-a519-779a0c245477